臨床試験を検索:ALO-02 (オキシコドン ナルトレキソン)
合計1133件
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene, Inc.完了マリファナの使用
-
Go Medical Industries Pty LtdNational Institute on Drug Abuse (NIDA); Columbia University; New York State Psychiatric Institute と他の協力者完了
-
NS Pharma, Inc.Nippon Shinyaku Co., Ltd.募集
-
Mundipharma Research GmbH & Co KG完了
-
Galectin Therapeutics Inc.完了
-
Axsome Therapeutics, Inc.わからない
-
Duke UniversityAlkermes, Inc.; Laura and John Arnold Foundation; FHR (Fellowship Health Resources, Inc.); Drug...完了
-
University of California, Los AngelesNational Institute on Drug Abuse (NIDA); The Emmes Company, LLC完了
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)完了
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)完了
-
Galectin Therapeutics Inc.完了
-
Eloxx Pharmaceuticals, Inc.SGS Life Sciences, a division of SGS Belgium NV完了
-
CNBG-Virogin Biotech (Shanghai) Ltd.Shulan (Hangzhou) Hospital募集
-
Prometheus LaboratoriesSyneos Health; Nestlé Health Science Spain終了しました
-
Boston UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)完了
-
University of OsloNorwegian Institute of Public Health; Oslo University Hospital; The Research Council of Norway; Ostfold... と他の協力者完了
-
TAK-Circulator Co.完了
-
Purdue Pharma LP完了
-
University of PennsylvaniaNational Institute on Drug Abuse (NIDA)完了
-
BioDelivery Sciences InternationalPRA Health Sciences完了
-
Alkermes, Inc.完了
-
Galectin Therapeutics Inc.Dr. Naga Chalasani, MD, Indiana University; Dr. Stephen A. Harrison, MD, Brooke Army Medical...完了